| scholarly article | Q13442814 |
| P2093 | author name string | Stephen J Marx | |
| P2860 | cites work | Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors | Q24337658 |
| Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications | Q24675796 | ||
| Minimally invasive pancreatic surgery - a review | Q26799294 | ||
| The same pocket in menin binds both MLL and JUND but has opposite effects on transcription | Q27677227 | ||
| GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism | Q29465815 | ||
| Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines. | Q30491060 | ||
| Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. | Q33438326 | ||
| Identification of somatic mutations in parathyroid tumors using whole-exome sequencing | Q33569943 | ||
| Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach? | Q33779718 | ||
| Gene Therapy 2017: Progress and Future Directions | Q33891559 | ||
| Guidelines for diagnosis and therapy of MEN type 1 and type 2. | Q34104591 | ||
| Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
| Breast-cancer predisposition in multiple endocrine neoplasia type 1. | Q34567651 | ||
| Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo | Q35557914 | ||
| Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. | Q35891227 | ||
| Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years | Q36069747 | ||
| MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients | Q36192096 | ||
| Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake. | Q36253935 | ||
| Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors | Q37056120 | ||
| Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states | Q37198026 | ||
| Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study | Q37581371 | ||
| MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches. | Q37633585 | ||
| Glucagon-like peptide-1: glucose homeostasis and beyond | Q38163602 | ||
| The future: surgical advances in MEN1 therapeutic approaches and management strategies | Q38642047 | ||
| Minimally Invasive Surgery for Pancreatic Disease - Current Status | Q38842465 | ||
| Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients | Q38852179 | ||
| Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer. | Q38920711 | ||
| Early and Late Complications After Surgery For MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors | Q39217965 | ||
| MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group | Q40282674 | ||
| Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group | Q40309700 | ||
| Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications | Q42392588 | ||
| The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1. | Q42458822 | ||
| Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies | Q43066318 | ||
| Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. | Q46477657 | ||
| Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival | Q46619794 | ||
| Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients | Q47751377 | ||
| The future: genetics advances in MEN1 therapeutic approaches and management strategies. | Q47814736 | ||
| Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group | Q47934699 | ||
| EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1. | Q50599727 | ||
| Whole-genome landscape of pancreatic neuroendocrine tumours. | Q51137102 | ||
| Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study. | Q51327209 | ||
| Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan. | Q52964090 | ||
| Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. | Q53914105 | ||
| The SNM practice guideline for somatostatin receptor scintigraphy 2.0. | Q55055175 | ||
| Minimally invasive parathyroidectomy | Q58686924 | ||
| Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene | Q60021403 | ||
| Robot-assisted spleen preserving pancreatic surgery in MEN1 patients | Q87585722 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple endocrine neoplasia | Q1553018 |
| P304 | page(s) | 1296-1301 | |
| P577 | publication date | 2018-04-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Recent Topics Around Multiple Endocrine Neoplasia Type 1. | |
| P478 | volume | 103 |
Search more.